Skip to main content
Michael Dube, MD, Infectious Disease, Los Angeles, CA, Keck Hospital of USC

MichaelPDubeMD

Infectious Disease Los Angeles, CA

Professor, Medicine, USC School of Medicine

Dr. Dube is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dube's full profile

Already have an account?

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Infectious Disease, 1990 - 1992
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1983 - 1986
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - 2025
  • IN State Medical License
    IN State Medical License 2000 - 2009
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex with Men  
    Jill Blumenthal, David J Moore, Michael P Dube, Sheldon R Morris, The Journal of Infectious Diseases

Press Mentions

  • Keck Medicine of USC Enrolling Volunteers to Test COVID-19 Drug
    Keck Medicine of USC Enrolling Volunteers to Test COVID-19 DrugNovember 19th, 2020
  • USC Seeking Vernon Factory Workers to Volunteer for COVID-19 Vaccine Trial
    USC Seeking Vernon Factory Workers to Volunteer for COVID-19 Vaccine TrialAugust 17th, 2020
  • Keck Medicine to Launch Clinical Trial for Coronavirus Treatment
    Keck Medicine to Launch Clinical Trial for Coronavirus TreatmentMay 7th, 2020

Grant Support

  • Switch To Atazanavir And Brachial Artery Reactivity (SABAR) Study: EndotheliaNational Center For Research Resources2007–2008
  • Cross-Sectional And Longitudinal Study Of Endothelial Function By Brachial Flow-National Center For Research Resources2007–2008
  • A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)National Center For Research Resources2007–2008
  • A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of UridineNational Center For Research Resources2007–2008
  • Pilot Study To Establish The Use Of Brachial Ultrasound To Measure Vascular RNational Center For Research Resources2006–2008
  • PLAN For Obtaining Informed Consent To Use Stored Human Biological MaterialsNational Center For Research Resources2004–2008
  • Effect Of HIV-1 Protease Inhibitors On Endothelial Function And GlucoseNational Center For Research Resources2004–2008
  • A Phase IIIB, Open-Label, Randomized, Multi-Center Study Comparing The AntiviNational Center For Research Resources2006
  • Immuno &Viro Indices To Study The HIV Disease Progression Assoc W/AgingNational Center For Research Resources2005–2006
  • A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, ParaNational Center For Research Resources2005–2006
  • A Phase II Trial Of The Effect Of Combination Therapy With Fish Oil SupplemenNational Center For Research Resources2005–2006
  • Trial Of Physiologic Testosterone Supplementation For Hiv-Positive(A5079)National Center For Research Resources2004–2006
  • Effect Of A Protease Inhibitor-Containing Or A Non-Protease Inhibitor-ContainingNational Center For Research Resources2004–2006
  • Study Of Metformin &Rosiglitazone Alone/In Combo In Hiv-Infected PTSNational Center For Research Resources2005
  • Thymidine Analogue Substitution Or Change To A Nucleoside-Sparing RegimenNational Center For Research Resources2004–2005
  • Extended-Release Niacin For The Treatment Of Elevated Non-Hdl CholesterolNational Center For Research Resources2004–2005
  • Alendronate In Hiv-Infected Subjects With Decreased Bone Mineral DensityNational Center For Research Resources2004–2005
  • Endothelial Dysfunction Due To HIV-1 Protease InhibitorsNational Heart, Lung, And Blood Institute2002–2005
  • Temporary Cessation Of ART &Resistance Testing In Response To Salvage TherapyNational Center For Research Resources2004
  • Study Of Metformin &Rosiglitazone Alone/In Combo In Hiv-Infected PTS.National Center For Research Resources2004
  • Immuno &Viro Indices To Study The HIV Disease Progression Assoc. W/AgingNational Center For Research Resources2004

Hospital Affiliations